Australian Health Practitioner Regulation Agency
 

Guidance issued on endorsements about scheduled medicines

09 Dec 2016

The Australian Health Workforce Ministerial Council (Ministerial Council) has recently endorsed Guidance for National Boards: Applications to the Ministerial Council for approval of endorsements in relation to scheduled medicines under section 14 of the National Law1 (the Guidance).

The Guidance is designed to be used by National Boards when preparing applications to the Ministerial Council for approval of an endorsement for scheduled medicines for their profession.

The objectives of the Guidance are to:

  • ensure robust, evidence-informed development and assessment of proposals for the use of scheduled medicines 
  • promote the safe and effective use of scheduled medicines 
  • facilitate common standards across professions for training and clinical practice with respect to the use of scheduled medicines, and/or 
  • facilitate nationally-consistent, core scheduled medicines authorities to enable innovation in health service delivery.

AHPRA and National Boards will be producing information for stakeholders to support the implementation of the Guidance. This is expected to be published in early 2017.

The Guidance is published on the AHPRA website, see the Ministerial directives and communiqués.


1Health Practitioner Regulation National Law, as in force in each state and territory.

 
 
 
Page reviewed 9/12/2016